0001593968-21-000225.txt : 20210128 0001593968-21-000225.hdr.sgml : 20210128 20210128112151 ACCESSION NUMBER: 0001593968-21-000225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210126 FILED AS OF DATE: 20210128 DATE AS OF CHANGE: 20210128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waltz Todd CENTRAL INDEX KEY: 0001383895 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36475 FILM NUMBER: 21563078 MAIL ADDRESS: STREET 1: P O BOX 1445 CITY: CUPERTINO STATE: CA ZIP: 95015 FORMER NAME: FORMER CONFORMED NAME: WELTZ TODD DATE OF NAME CHANGE: 20061218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEMETIS, INC CENTRAL INDEX KEY: 0000738214 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 261407544 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 408-517-3304 MAIL ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: AE BIOFUELS, INC. DATE OF NAME CHANGE: 20110714 FORMER COMPANY: FORMER CONFORMED NAME: AE Biofuels, Inc. DATE OF NAME CHANGE: 20071212 FORMER COMPANY: FORMER CONFORMED NAME: MARWICH II LTD DATE OF NAME CHANGE: 19840123 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-01-26 0000738214 AEMETIS, INC AMTX 0001383895 Waltz Todd 20400 STEVENS CREK BLVD, SUITE 700 CUPERTINO CA 95014 false true false false Executive Vice President, CFO Option (right to buy) 4.35 2021-01-26 4 D false 10000 9.0609 D 2015-08-21 2022-05-21 Common stock and Series B Preferred 10000 0 D The 10,000 shares were exercised from grant 5/21/2015 and sold through executing the 10b5-1 plan. 1/12th of the Option Shares vest every three(3)months from the date of the grant. Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 20,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $4.35 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. /s/ Todd Waltz 2021-01-28